
Why BioNexus is Betting Its Treasury on Ethereum, Not Bitcoin
BioNexus Gene Lab Corporation, based in Wyoming, chooses Ethereum over Bitcoin as its exclusive strategic asset for treasury management. The decision is backed by Ethereum’s capabilities, including staking yields of 3-5% annually, positioning it as an income-generating asset. Ethereum’s role as a